Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction
Authors:
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Myocardial infarction triage and intervention project—Phase I: Patient characteristics and feasibility of prehospital initiation of thrombolytic therapyJACC, 1990
- Intracranial hemorrhage after rt-pa and heparin for acute myocardial infarction — The TIMI II pilot and randomized trial combined experienceJACC, 1990
- The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: Results from thrombolysis in myocardial infarction phase I, open label studies and the thrombolysis in myocardial infarction phase II pilot studyJACC, 1989
- Age variation in the association between angiographic coronary disease and angina from the Coronary Artery Surgery Study (CASS)International Journal of Cardiology, 1989
- A community survey of the potential use of thrombolytic agents for acute myocardial infarctionAnnals of Emergency Medicine, 1989
- Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.BMJ, 1988
- Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patientsThe American Journal of Cardiology, 1988
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJACC, 1988
- Update from the thrombolysis in myocardial infarction trialJACC, 1987
- Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS).Circulation, 1981